theflyonthewall.com: the Fastest Breaking Financial and Equity News on the Web

News Breaks

October 29, 2009

16:14 EDT

DVAX

theflyonthewall.com:		Dynavax's Phase III Heplisav study shows increased kidney protection
		Dynavax Technologies will show phase 3 clinical data for Heplisav investigational Hepatitis B vaccine in chronic kidney disease patients at the Infectious Disease Society of America annual meeting on 31 October. Patients demonstrated increased protection against hepatitis B in fewer doses than patients receiving licensed vaccine. :theflyonthewall.com

News For DVAX From The Last 14 Days

Check below for free stories on DVAX the last two weeks.

There are 3 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.

February 13, 2012

09:05 EDT

DVAX

theflyonthewall.com:		Dynavax Heplislav Phase lll data published in Vaccine
		Subscribe for More Information :theflyonthewall.com

February 2, 2012

12:56 EDT

DVAX

theflyonthewall.com:		Dynavax expanded Heplisav label a significant positive, says William Blair
		Subscribe for More Information :theflyonthewall.com

10:17 EDT

DVAX

theflyonthewall.com:		Dynavax should seek broad label for Heplisav, says Cowen
		Subscribe for More Information :theflyonthewall.com